Clinical Trial Update: MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users [Phase 4]

View source ↗

Summary

Phase 4 trial comparing MBRP plus vortioxetine versus MBRP alone for relapse prevention in chronic methamphetamine users.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Major Depressive Disorder
• Relapse of Methamphetamine Use Disorder

Drugs mentioned

• MBRP
• Vortioxetine (vortioxetine)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Relapse, Cognitive Impairment | Phase 4 | Status: UNKNOWN